ME00379B - Memno peptidi, postupak za njihovo pripremanje i njihova primjena - Google Patents

Memno peptidi, postupak za njihovo pripremanje i njihova primjena

Info

Publication number
ME00379B
ME00379B MEP-2008-591A MEP59108A ME00379B ME 00379 B ME00379 B ME 00379B ME P59108 A MEP59108 A ME P59108A ME 00379 B ME00379 B ME 00379B
Authority
ME
Montenegro
Prior art keywords
preparation
memno peptides
memno
peptides
dsm
Prior art date
Application number
MEP-2008-591A
Other languages
English (en)
Inventor
Laszlo Vertesy
Herbert Kogler
Astrid Markus
Matthias Schiell
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of MEP59108A publication Critical patent/MEP59108A/xx
Publication of ME00379B publication Critical patent/ME00379B/me

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Pronalazak se odnosi na derivate peptida, poznate kao memno peptidi, formule (I):gdje R1, R2, R3, R4, R5, R6, R7, R8 i (A)n imaju ovdje data značenja, koja se mogu dobitigajenjem Memnoniella echinata FH 2272, DSM 13195 ili njenih mutanata i varijanata, napostupak za njihovo dobijanje i na upotrebu jedinjenja kao farmaceutskih preparata, naprimjer za liječenje srčane insuficijencije.
MEP-2008-591A 2000-02-29 2001-02-15 Memno peptidi, postupak za njihovo pripremanje i njihova primjena ME00379B (me)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00104114A EP1130027A1 (de) 2000-02-29 2000-02-29 Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
PCT/EP2001/001661 WO2001064715A2 (en) 2000-02-29 2001-02-15 Memno peptides, a process for their preparation and their use

Publications (2)

Publication Number Publication Date
MEP59108A MEP59108A (en) 2011-05-10
ME00379B true ME00379B (me) 2011-05-10

Family

ID=8167973

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-2008-591A ME00379B (me) 2000-02-29 2001-02-15 Memno peptidi, postupak za njihovo pripremanje i njihova primjena

Country Status (30)

Country Link
US (1) US6627604B2 (me)
EP (2) EP1130027A1 (me)
JP (1) JP4787449B2 (me)
KR (1) KR100997073B1 (me)
CN (1) CN1274715C (me)
AR (1) AR029808A1 (me)
AT (1) ATE313556T1 (me)
AU (2) AU2001250318B2 (me)
BR (1) BR0108757A (me)
CA (1) CA2401032C (me)
CY (1) CY1105550T1 (me)
CZ (1) CZ303552B6 (me)
DE (1) DE60116063T2 (me)
DK (1) DK1261625T3 (me)
EE (1) EE05406B1 (me)
ES (1) ES2254394T3 (me)
HK (1) HK1052712B (me)
HR (1) HRP20020703B1 (me)
HU (1) HU228067B1 (me)
IL (2) IL151458A0 (me)
ME (1) ME00379B (me)
MX (1) MXPA02007845A (me)
NO (1) NO329082B1 (me)
NZ (1) NZ521036A (me)
PL (1) PL206818B1 (me)
RU (1) RU2261254C2 (me)
SI (1) SI1261625T1 (me)
SK (1) SK287310B6 (me)
WO (1) WO2001064715A2 (me)
ZA (1) ZA200206841B (me)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308613B1 (it) * 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
DE10050091A1 (de) * 2000-10-09 2002-04-25 Biotechnolog Forschung Gmbh Casein-Peptidfragmente mit wachstumsbeeinflußender Aktivität auf Zellkulturen
ITMI20010129A1 (it) * 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
DE10258650A1 (de) * 2002-12-13 2004-06-24 Aventis Pharma Deutschland Gmbh Neue Spirobenzofuranlactame und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
US7160917B2 (en) * 2002-12-13 2007-01-09 Sanofi-Aventis Deutschland Gmbh Spirobenzofuran lactams and their derivatives, processes for their preparation and use thereof
DE102012016127A1 (de) 2011-08-31 2013-02-28 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004530A1 (en) * 1993-08-06 1995-02-16 Smithkline Beecham Corporation Endothelin receptor antagonists
JPH07330622A (ja) * 1994-06-06 1995-12-19 Asahi Chem Ind Co Ltd 新規生理活性物質スタキボシンｄ及びその製法
JPH08283118A (ja) * 1995-04-07 1996-10-29 Kao Corp 美白剤
JPH10251262A (ja) * 1997-01-13 1998-09-22 Mercian Corp プロテアーゼ阻害物質およびその製造方法
DE19731571A1 (de) * 1997-07-23 1999-01-28 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19754082A1 (de) * 1997-12-05 1999-06-10 Knoll Ag Methode zur Bekämpfung der Fettleibigkeit
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben

Also Published As

Publication number Publication date
BR0108757A (pt) 2002-12-10
EP1261625A2 (en) 2002-12-04
AU5031801A (en) 2001-09-12
SK12262002A3 (sk) 2003-02-04
US6627604B2 (en) 2003-09-30
RU2002125877A (ru) 2004-01-10
KR20020077508A (ko) 2002-10-11
NO20024105D0 (no) 2002-08-28
IL151458A0 (en) 2003-04-10
HRP20020703B1 (en) 2011-01-31
AR029808A1 (es) 2003-07-16
KR100997073B1 (ko) 2010-11-30
NO20024105L (no) 2002-10-28
EE200200480A (et) 2004-02-16
US20010031857A1 (en) 2001-10-18
MEP59108A (en) 2011-05-10
RU2261254C2 (ru) 2005-09-27
NO329082B1 (no) 2010-08-16
ES2254394T3 (es) 2006-06-16
IL151458A (en) 2008-08-07
EP1130027A1 (de) 2001-09-05
HUP0204584A3 (en) 2005-09-28
SI1261625T1 (sl) 2006-04-30
EP1261625B1 (en) 2005-12-21
JP4787449B2 (ja) 2011-10-05
ATE313556T1 (de) 2006-01-15
CA2401032C (en) 2012-04-10
WO2001064715A3 (en) 2002-03-21
AU2001250318B2 (en) 2005-09-08
HUP0204584A2 (hu) 2003-04-28
DE60116063D1 (de) 2006-01-26
CA2401032A1 (en) 2001-09-07
NZ521036A (en) 2004-02-27
CY1105550T1 (el) 2010-07-28
WO2001064715A2 (en) 2001-09-07
DK1261625T3 (da) 2006-04-18
CN1406243A (zh) 2003-03-26
CN1274715C (zh) 2006-09-13
ZA200206841B (en) 2003-07-03
HK1052712A1 (en) 2003-09-26
PL206818B1 (pl) 2010-09-30
HRP20020703A2 (en) 2004-12-31
DE60116063T2 (de) 2006-08-03
HU228067B1 (en) 2012-09-28
MXPA02007845A (es) 2002-11-29
JP2004512257A (ja) 2004-04-22
EE05406B1 (et) 2011-04-15
SK287310B6 (sk) 2010-06-07
HK1052712B (zh) 2007-01-12
PL358300A1 (en) 2004-08-09
CZ303552B6 (cs) 2012-12-05
CZ20022904A3 (cs) 2002-11-13

Similar Documents

Publication Publication Date Title
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
DE60112609D1 (en) Pyrazolopyridine
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
DE60009511D1 (de) Nematizide trifluorbutene
ME00595B (me) 2-okso-1-pirolidinski derivati, postupci za njihovo dobijanje i njihove primene
YU56995A (sh) Soli derivata indola
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
DE602004021472D1 (en) Pyrimiidinverbindungen
EA200801011A1 (ru) Производные пиразина как модуляторы натриевых каналов для лечения боли
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
HK1069169A1 (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
DE60112330D1 (en) Pyrazolopyridinderivate
EP1689713A4 (en) BENZYLETHER AND BETA-SECRETASE BENZYLAMINO INHIBITORS FOR TREATING ALZHEIMER'S DISEASE
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
DE60024857D1 (de) Neue verbindungen
CY1105550T1 (el) Μεμνο-πεπτιδια, μια διαδικασια για την παρασκευη και τη χρηση τους
MXPA02012426A (es) Compuestos nuevos.
PL328225A1 (en) Diphenylstilbenes as pro-medications used to produce cox-2-inhibitors
IL165220A0 (en) Novel compounds, their use and preparation
DE60201074D1 (en) Pyrazolopyridinderivate
YU37597A (en) New pyranosid derivatives
AU6826700A (en) Ceramide analogs, process for their preparation and their use as antitumor agents
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents